Cargando…
Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma
BACKGROUND: The determination of HER2 expression status contributes significantly to HER2-targeted therapy in breast carcinoma. However, an economical, efficient, and non-invasive assessment of HER2 is lacking. We aimed to develop a clinicoradiomic nomogram based on radiomics scores extracted from m...
Autores principales: | Xu, Aqiao, Chu, Xiufeng, Zhang, Shengjian, Zheng, Jing, Shi, Dabao, Lv, Shasha, Li, Feng, Weng, Xiaobo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364617/ https://www.ncbi.nlm.nih.gov/pubmed/35945526 http://dx.doi.org/10.1186/s12885-022-09967-6 |
Ejemplares similares
-
Prediction Breast Molecular Typing of Invasive Ductal Carcinoma Based on Dynamic Contrast Enhancement Magnetic Resonance Imaging Radiomics Characteristics: A Feasibility Study
por: Xu, Aqiao, et al.
Publicado: (2022) -
Construction and Validation of a Novel Nomogram for Predicting the Risk of Metastasis in a Luminal B Type Invasive Ductal Carcinoma Population
por: Zhu, Xu Dong, et al.
Publicado: (2023) -
An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast
por: Kim, Sanghwa, et al.
Publicado: (2019) -
Development and Validation of an Ultrasound-Based Radiomics Nomogram for Identifying HER2 Status in Patients with Breast Carcinoma
por: Guo, Yinghong, et al.
Publicado: (2022) -
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer
por: Fornaro, Lorenzo, et al.
Publicado: (2019)